SE OF DEXMEDITOMIDINE TO REDUCE HEART RATE AND B.P IN ELECTRIC SHOCK THERAPY IN PSYCHIATRIC PATIENTS
Not Applicable
- Conditions
- Health Condition 1: F063- Mood disorder due to known physiological condition
- Registration Number
- CTRI/2023/12/060406
- Lead Sponsor
- SIMRAN NATHANI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PATIENTS SCHEDULED FOR ECT
ALL PATIENTS UNDER ASA I AMD II
Exclusion Criteria
CARDIOVASCULAR DISEASE
PT ON BETA BLOCKERS
PRE EXISITING BRADYCARDIA
NON CONSENT TO PARTICIPATE IN STUDY
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DEXMEDETOMIDINE IS EFFECTIVE IN ATTENUATION OF HYPERDYNAMIC PRESSOR RESPONSE IN ECTTimepoint: BEFORE GIVING DRUG <br/ ><br>2 MINS AFTER GIVING DRUG <br/ ><br>BEFORE SHOCK <br/ ><br>AFTER SHOCK <br/ ><br>AT TIME OF SHIFTING TO RECOVERY <br/ ><br>
- Secondary Outcome Measures
Name Time Method SEDATION SCORE <br/ ><br>DURATION OF SEIZURES AFTER SHOCKTimepoint: BEFORE GIVING DRUG <br/ ><br>2 MINS AFTER GIVING DRUG <br/ ><br>BEFORE SHOCK <br/ ><br>AFTER SHOCK <br/ ><br>AT TIME OF SHIFTING TO RECOVERY